Pharma Litigation Attorneys Pen Article for Law360
Taft Chicago Pharmaceutical and Life Sciences Litigation attorneys Stephen Auten and Jaimin Shah along with Sinchan Shah of Amneal Pharmaceuticals Pvt. Ltd. published “For Now, Competitive Generic Therapy Exclusivity is a Mirage” for Law360. The article discusses issues with competitive generic therapy exclusivity enacted in the Food and Drug Reauthorization Act of 2017.
In This Article
You May Also Like
Bautista Moderates NFALA Panel on Business Development Strategies Auten and Shrestha to Present at 13th Annual Pharma IPR Conference